ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 646101 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 646101; 2) Community: the network communities that were significantly associated with the response to NSC 646101; 3) Molecule: the relationships between components within communities and NSC 646101; 4) MDR: the compounds that were significantly associated with the NSC 646101.

NSC Compound Enrichment Correlation
NSC 614491 8-Cl-cAMP, sodium salt 0.0247898374452139 -0.060070709
NSC 623520 Null 0.0247898374452139 -0.24680484
NSC 624512 Null 0.0247898374452139 -0.16935339
NSC 627759 2'-Phenyl-17a-aza-D-homo-5-androsteno[17,16-c]pyrazol-3.beta.-yl acetate 0.0247898374452139 -0.32826762
NSC 637220 cis-Difluorobis(1-phenylhexane-1,3-dionato)titanium(IV) 0.0247898374452139 -0.29147597
NSC 672453 Null 0.0247898374452139 -0.18147341
NSC 677174 Null 0.0247898374452139 -0.18104331
NSC 682764 Pyrido[3,2-d][1]benzazepin-6-one, 4-(4-chlorophenyl)-2-phenyl- 0.0247898374452139 0.067839377
NSC 691127 Null 0.0247898374452139 -0.13289525
NSC 693986 Pyrimidine-2,4(1H,3H)-dione, 1-[1,2-bis(ethoxycarbonyl)ethenyl]-5-methyl-3-propynyl-, (E)-, 0.0247898374452139 -0.099004408
Total:53  Current:25    [First] [Prev] [Next] [Last]